Literature DB >> 33166408

The transition of M-CSF-derived human macrophages to a growth-promoting phenotype.

Kajal Hamidzadeh1, Ashton T Belew1,2, Najib M El-Sayed1,2, David M Mosser1.   

Abstract

Stimulated macrophages are potent producers of inflammatory mediators. This activity is highly regulated, in part, by resolving molecules to prevent tissue damage. In this study, we demonstrate that inflammation induced by Toll-like receptor stimulation is followed by the upregulation of receptors for adenosine (Ado) and prostaglandin E2 (PGE2), which help terminate macrophage activation and initiate tissue remodeling and angiogenesis. Macrophages can be hematopoietically derived from monocytes in response to 2 growth factors: macrophage colony-stimulating factor (M-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF). We examine how exposure to either of these differentiation factors shapes the macrophage response to resolving molecules. We analyzed the transcriptomes of human monocyte-derived macrophages stimulated in the presence of Ado or PGE2 and demonstrated that, in macrophages differentiated in M-CSF, Ado and PGE2 induce a shared transcriptional program involving the downregulation of inflammatory mediators and the upregulation of growth factors. In contrast, macrophages generated in GM-CSF fail to convert to a growth-promoting phenotype, which we attribute to the suppression of receptors for Ado and PGE2 and lower production of these endogenous regulators. These observations indicate that M-CSF macrophages are better prepared to transition to a program of tissue repair, whereas GM-CSF macrophages undergo more profound activation. We implicate the differential sensitivity to pro-resolving mediators as a contributor to these divergent phenotypes. This research highlights a number of molecular targets that can be exploited to regulate the strength and duration of macrophage activation.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33166408      PMCID: PMC7656919          DOI: 10.1182/bloodadvances.2020002683

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  54 in total

Review 1.  Regulation of macrophage function by adenosine.

Authors:  György Haskó; Pál Pacher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-04       Impact factor: 8.311

Review 2.  Signalling by the βc family of cytokines.

Authors:  Timothy R Hercus; Urmi Dhagat; Winnie L T Kan; Sophie E Broughton; Tracy L Nero; Michelle Perugini; Jarrod J Sandow; Richard J D'Andrea; Paul G Ekert; Timothy Hughes; Michael W Parker; Angel F Lopez
Journal:  Cytokine Growth Factor Rev       Date:  2013-03-25       Impact factor: 7.638

3.  Homozygous Mutations in CSF1R Cause a Pediatric-Onset Leukoencephalopathy and Can Result in Congenital Absence of Microglia.

Authors:  Nynke Oosterhof; Irene J Chang; Ehsan Ghayoor Karimiani; Laura E Kuil; Dana M Jensen; Ray Daza; Erica Young; Lee Astle; Herma C van der Linde; Giridhar M Shivaram; Jeroen Demmers; Caitlin S Latimer; C Dirk Keene; Emily Loter; Reza Maroofian; Tjakko J van Ham; Robert F Hevner; James T Bennett
Journal:  Am J Hum Genet       Date:  2019-04-11       Impact factor: 11.025

4.  Circulating levels of granulocyte macrophage colony-stimulating factor in patients with the systemic inflammatory response syndrome.

Authors:  Donato Torre; Roberto Tambini; Mariangela Manfredi; Valerio Mangani; Paola Livi; Viviana Maldifassi; Maurizio Chiaranda; Paolo Campi; Filippo Speranza
Journal:  J Infect       Date:  2003-11       Impact factor: 6.072

Review 5.  Colony stimulating factors and myeloid cell biology in health and disease.

Authors:  John A Hamilton; Adrian Achuthan
Journal:  Trends Immunol       Date:  2012-09-21       Impact factor: 16.687

6.  CXCL13 promotes the effect of bone marrow mesenchymal stem cells (MSCs) on tendon-bone healing in rats and in C3HIOT1/2 cells.

Authors:  Feng Tian; Xiang-Lu Ji; Wan-An Xiao; Bin Wang; Fei Wang
Journal:  Int J Mol Sci       Date:  2015-01-30       Impact factor: 5.923

7.  Extracellular Purine Metabolism Is the Switchboard of Immunosuppressive Macrophages and a Novel Target to Treat Diseases With Macrophage Imbalances.

Authors:  Anna Ohradanova-Repic; Christian Machacek; Celine Charvet; Franck Lager; Delphine Le Roux; René Platzer; Vladimir Leksa; Goran Mitulovic; Thomas R Burkard; Gerhard J Zlabinger; Michael B Fischer; Vincent Feuillet; Gilles Renault; Stephan Blüml; Miroslav Benko; Miloslav Suchanek; Johannes B Huppa; Takami Matsuyama; Artur Cavaco-Paulo; Georges Bismuth; Hannes Stockinger
Journal:  Front Immunol       Date:  2018-04-27       Impact factor: 7.561

8.  A Macrophage-Pericyte Axis Directs Tissue Restoration via Amphiregulin-Induced Transforming Growth Factor Beta Activation.

Authors:  Carlos M Minutti; Rucha V Modak; Felicity Macdonald; Fengqi Li; Danielle J Smyth; David A Dorward; Natalie Blair; Connor Husovsky; Andrew Muir; Evangelos Giampazolias; Ross Dobie; Rick M Maizels; Timothy J Kendall; David W Griggs; Manfred Kopf; Neil C Henderson; Dietmar M Zaiss
Journal:  Immunity       Date:  2019-02-12       Impact factor: 31.745

9.  Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy.

Authors:  Anujan Ramesh; Anthony Brouillard; Sahana Kumar; Dipika Nandi; Ashish Kulkarni
Journal:  Biomaterials       Date:  2019-10-19       Impact factor: 12.479

10.  CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models.

Authors:  Yu Zhu; Brett L Knolhoff; Melissa A Meyer; Timothy M Nywening; Brian L West; Jingqin Luo; Andrea Wang-Gillam; S Peter Goedegebuure; David C Linehan; David G DeNardo
Journal:  Cancer Res       Date:  2014-07-31       Impact factor: 12.701

View more
  3 in total

1.  Derivation of extra-embryonic and intra-embryonic macrophage lineages from human pluripotent stem cells.

Authors:  Andrea L Bredemeyer; Junedh M Amrute; Andrew L Koenig; Rachel A Idol; Li He; Stephanie A Luff; Carissa Dege; Jamison M Leid; Joel D Schilling; J Travis Hinson; Mary C Dinauer; Christopher M Sturgeon; Kory J Lavine
Journal:  Development       Date:  2022-05-03       Impact factor: 6.862

2.  Bone Marrow Soluble Mediator Signatures of Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.

Authors:  Juçara Gastaldi Cominal; Maira da Costa Cacemiro; Maria Gabriela Berzoti-Coelho; Illy Enne Gomes Pereira; Fabiani Gai Frantz; Elizabeth Xisto Souto; Dimas Tadeu Covas; Lorena Lobo de Figueiredo-Pontes; Maria Carolina Oliveira; Kelen Cristina Ribeiro Malmegrim; Fabíola Attié de Castro
Journal:  Front Oncol       Date:  2021-05-18       Impact factor: 6.244

3.  Targeting fatty acid β-oxidation impairs monocyte differentiation and prolongs heart allograft survival.

Authors:  Yuehui Zhu; Hao Dun; Li Ye; Yuriko Terada; Leah P Shriver; Gary J Patti; Daniel Kreisel; Andrew E Gelman; Brian W Wong
Journal:  JCI Insight       Date:  2022-04-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.